These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22361621)

  • 1. The Charcot joint: a modern neurologic perspective.
    Chisholm KA; Gilchrist JM
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):1-13. PubMed ID: 22361621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of body mass index in acute charcot neuroarthropathy.
    Ross AJ; Mendicino RW; Catanzariti AR
    J Foot Ankle Surg; 2013; 52(1):6-8. PubMed ID: 23260985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV neuropathy induced Charcot neuroarthropathy: a case discussion.
    Young N; Neiderer K; Martin B; Jolley D; Dancho JF
    Foot (Edinb); 2012 Sep; 22(3):112-6. PubMed ID: 22391513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charcot neuroarthropathy: An often overlooked complication of diabetes.
    Botek G; Anderson MA; Taylor R
    Cleve Clin J Med; 2010 Sep; 77(9):593-9. PubMed ID: 20810870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
    Gough A; Abraha H; Li F; Purewal TS; Foster AV; Watkins PJ; Moniz C; Edmonds ME
    Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charcot Neuroarthropathy of the Foot and Ankle.
    Burson LK; Schank CH
    Home Healthc Now; 2016 Mar; 34(3):135-9. PubMed ID: 26925938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
    Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J
    Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrared dermal thermometry is highly reliable in the assessment of patients with Charcot neuroarthropathy.
    Dallimore SM; Puli N; Kim D; Kaminski MR
    J Foot Ankle Res; 2020 Sep; 13(1):56. PubMed ID: 32928270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.
    Rizzo P; Pitocco D; Zaccardi F; Di Stasio E; Strollo R; Rizzi A; Scavone G; Costantini F; Galli M; Tinelli G; Flex A; Caputo S; Pozzilli P; Landolfi R; Ghirlanda G; Nissim A
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27454862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of genetic factors and monocyte-to-osteoclast differentiation in the pathogenesis of Charcot neuroarthropathy.
    Kloska A; Korzon-Burakowska A; Malinowska M; Bruhn-Olszewska B; Gabig-Cimińska M; Jakóbkiewicz-Banecka J
    Diabetes Res Clin Pract; 2020 Aug; 166():108337. PubMed ID: 32707214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcot neuroarthropathy in diabetes mellitus.
    Rajbhandari SM; Jenkins RC; Davies C; Tesfaye S
    Diabetologia; 2002 Aug; 45(8):1085-96. PubMed ID: 12189438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic Charcot neuroarthropathy: The diagnosis must be considered in all diabetic neuropathic patients presenting with a hot, swollen foot.
    Al-Busaidi IS; Mason R; Lunt H
    N Z Med J; 2015 Oct; 128(1423):77-80. PubMed ID: 26645758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.
    Nehring P; Mrozikiewicz-Rakowska B; Maroszek P; Sobczyk-Kopcioł A; Krzyżewska M; Płoski R; Karnafel W
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):31-4. PubMed ID: 24203651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic neuroarthropathy of the foot and ankle.
    Scartozzi G; Kanat IO
    J Am Podiatr Med Assoc; 1990 Jun; 80(6):298-303. PubMed ID: 2189987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy.
    Korzon-Burakowska A; Jakóbkiewicz-Banecka J; Fiedosiuk A; Petrova N; Koblik T; Gabig-Cimińska M; Edmonds M; Małecki MT; Węgrzyn G
    Diabet Med; 2012 Jun; 29(6):771-5. PubMed ID: 21913967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charcot neuroarthropathy triggered and complicated by osteomyelitis. How limb salvage can be achieved.
    Aragón-Sánchez J; Lázaro-Martínez JL; Quintana-Marrero Y; Álvaro-Afonso FJ; Hernández-Herrero MJ
    Diabet Med; 2013 Jun; 30(6):e229-32. PubMed ID: 23590722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charcot arthropathy of the foot and ankle associated with rheumatoid arthritis.
    Grear BJ; Rabinovich A; Brodsky JW
    Foot Ankle Int; 2013 Nov; 34(11):1541-7. PubMed ID: 23900228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Charcot joint in diabetes.
    Klenerman L
    Diabet Med; 1996; 13 Suppl 1():S52-4. PubMed ID: 8741831
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
    Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
    Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charcot Foot: Clinical Clues, Diagnostic Strategies, and Treatment Principles.
    Marmolejo VS; Arnold JF; Ponticello M; Anderson CA
    Am Fam Physician; 2018 May; 97(9):594-599. PubMed ID: 29763252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.